Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
U-Cytech Biosciences is a Dutch biotechnology company specializing in the development and manufacturing of high-quality ELISPOT and ELISA kits, as well as monoclonal antibodies and recombinant proteins. Founded in 1999 as a spin-off from Utrecht University and the Biomedical Primate Research Centre, the company focuses on cytokine research tools for human, monkey, and rodent models. Their products are essential for monitoring immune responses in vaccine development, infectious disease research, and clinical trials. U-Cytech is particularly recognized for its extensive portfolio of non-human primate cytokine assays, supporting translational research. The company operates as a commercial-stage entity, providing validated reagents to academic and industrial researchers worldwide. Their offerings also include Fluorospot kits for the simultaneous detection of multiple cytokines at the single-cell level.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U-Cytech Biosciences.